Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

Clinical pharmacogenetics and potential application in personalized medicine

SF Zhou, Y Ming Di, E Chan, YM Du… - Current drug …, 2008 - ingentaconnect.com
The current 'fixed-dosage strategy'approach to medicine, means there is much inter-
individual variation in drug response. Pharmacogenetics is the study of how inter-individual …

Mechanisms of multidrug resistance in cancer

JP Gillet, MM Gottesman - Multi-drug resistance in cancer, 2010 - Springer
The development of multidrug resistance (MDR) to chemotherapy remains a major
challenge in the treatment of cancer. Resistance exists against every effective anticancer …

CYP2C9 Genotype‐guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study

Y Caraco, S Blotnick, M Muszkat - Clinical Pharmacology & …, 2008 - Wiley Online Library
Warfarin anticoagulation effect is characterized by marked variability, some of which has
been attributed to CYP2C9 polymorphisms. This study prospectively examines whether a …

Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals

M Rotger, H Tegude, S Colombo… - Clinical …, 2007 - Wiley Online Library
To assess the association of CYP2B6 allelic diversity with efavirenz (EFV) pharmacokinetics,
we performed extensive genoty** of 15 relevant single nucleotide polymorphism in 169 …

Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy …

K Klein, T Lang, T Saussele… - Pharmacogenetics …, 2005 - journals.lww.com
The present study investigated CYP2B6 genetic variability by sequencing genomic DNA
samples of African-American, Ghanaian, Taiwanese, Japanese and Korean subjects …

Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro

Z Desta, T Saussele, B Ward, J Blievernicht, L Li… - 2007 - Taylor & Francis
Objectives: To determine the influence of cytochrome P450 2B6 (CYP2B6) genotype on the
rate of oxidative efavirenz metabolism in human liver microsomes. Materials & methods …

Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6* 6 and* 26

H Gatanaga, T Hayashida, K Tsuchiya… - Clinical infectious …, 2007 - academic.oup.com
Background. Efavirenz (EFV) is metabolized primarily by cytochrome P450 2B6 (CYP2B6),
and high plasma concentrations of the drug are associated with a G→ T polymorphism at …

Adherence-resistance relationships to combination HIV antiretroviral therapy

DR Bangsberg, DL Kroetz, SG Deeks - Current HIV/AIDS Reports, 2007 - Springer
Early views on the relationship between adherence and resistance postulated a bell-shaped
relationship that balanced selective drug pressure and improved viral suppression along a …

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants

ER Holzinger, B Grady, MD Ritchie… - Pharmacogenetics …, 2012 - journals.lww.com
Objectives Prior candidate gene studies have associated CYP2B6 516G→ T [rs3745274]
and 983T→ C [rs28399499] with increased plasma efavirenz exposure. We sought to …